Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 063666/0326 | |
| Pages: | 8 |
| | Recorded: | 05/17/2023 | | |
| Attorney Dkt #: | 2002317 PAT |
| Conveyance: | AMENDMENT TO PREVIOUSLY FILED SECURITY INTEREST |
|
|
Total properties:
10
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/22/2023
|
Application #:
|
17233830
|
Filing Dt:
|
04/19/2021
|
|
Publication #:
|
|
Pub Dt:
|
02/24/2022
| | | | |
|
Title:
|
COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/06/2023
|
Application #:
|
17234349
|
Filing Dt:
|
04/19/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/31/2022
| | | | |
|
Title:
|
PYRAZOLO[1,5]PYRIMIDINE-BASED COMPOUNDS AND METHODS OF THEIR USE TO TREAT VIRAL INFECTIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17539548
|
Filing Dt:
|
12/01/2021
|
|
Publication #:
|
|
Pub Dt:
|
03/24/2022
| | | | |
|
Title:
|
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17574977
|
Filing Dt:
|
01/13/2022
|
|
Publication #:
|
|
Pub Dt:
|
11/24/2022
| | | | |
|
Title:
|
COMPOUNDS AND METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASES AND CONDITIONS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17629166
|
Filing Dt:
|
01/21/2022
|
|
Publication #:
|
|
Pub Dt:
|
08/25/2022
| | | | |
|
Title:
|
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17631191
|
Filing Dt:
|
01/28/2022
|
|
Publication #:
|
|
Pub Dt:
|
08/04/2022
| | | | |
|
Title:
|
CONTINUOUS PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17631209
|
Filing Dt:
|
01/28/2022
|
|
Publication #:
|
|
Pub Dt:
|
07/28/2022
| | | | |
|
Title:
|
PROCESS FOR PREPARING THE CRYSTALLINE FORM II OF SOTAGLIFLOZIN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18095058
|
Filing Dt:
|
01/10/2023
|
|
Publication #:
|
|
Pub Dt:
|
07/13/2023
| | | | |
|
Title:
|
COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18114050
|
Filing Dt:
|
02/24/2023
|
|
Publication #:
|
|
Pub Dt:
|
11/09/2023
| | | | |
|
Title:
|
METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF AN AAK1 INHIBITOR
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18114104
|
Filing Dt:
|
02/24/2023
|
|
Publication #:
|
|
Pub Dt:
|
11/09/2023
| | | | |
|
Title:
|
SOLID FORMS OF (S)-1-((2',6-BIS(DIFLUOROMETHYL)-[2,4'-BIPYRIDIN]-5-YL)OXY)-2,4-DIMETHYLPENTAN-2-AMINE AND SALTS THEREOF
|
|
|
Assignee
|
|
|
|
|
| 115 SOUTH UNION STREET, SUITE 300 |
| ALEXANDRIA, VIRGINIA 22314 |
|
|
Correspondence name and address
|
| |
JAY DASILVA
|
| |
1025 CONNECTICUT AVE., NW, STE. 712
|
| |
COGENCY GLOBAL INC.
|
| |
WASHINGTON, DC 20036
|
Search Results as of:
05/12/2024 01:28 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
